Jeff Garro
Stock Analyst at Stephens & Co.
(0.62)
# 3,945
Out of 4,924 analysts
50
Total ratings
23.53%
Success rate
-14.25%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $13.04 | +53.37% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.72 | +35.14% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $282.65 | -0.94% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $3.82 | +30.89% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $9.53 | +78.38% | 5 | Feb 27, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $9.41 | +27.52% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $19.81 | +31.28% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $3.94 | +27.06% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $58.13 | -5.38% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $12.50 | -55.98% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $177.49 | +40.85% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $18.70 | -9.09% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $27.11 | +3.28% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $6.99 | +300.57% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $13.71 | +45.93% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.40 | +14.71% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.90 | +57.89% | 3 | May 6, 2022 |
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $13.04
Upside: +53.37%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.72
Upside: +35.14%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $282.65
Upside: -0.94%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.82
Upside: +30.89%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $9.53
Upside: +78.38%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.41
Upside: +27.52%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $19.81
Upside: +31.28%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $3.94
Upside: +27.06%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $58.13
Upside: -5.38%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $12.50
Upside: -55.98%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $177.49
Upside: +40.85%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $18.70
Upside: -9.09%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $27.11
Upside: +3.28%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $6.99
Upside: +300.57%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $13.71
Upside: +45.93%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.40
Upside: +14.71%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.90
Upside: +57.89%